• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
S,S-(+)-Tetrandrine

S,S-(+)-Tetrandrine

Product ID T1777
Cas No. 518-34-3
Purity ≥98%
Product Unit SizeCostQuantityStock
100 mg $86.80 In stock
500 mg $236.50 In stock
1 g $364.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

S,S-Tetrandrine is a benzylisoquinoline alkaloid originally found in Stephania that exhibits anti-inflammatory, anti-allergic, analgesic, neuroprotective, cognition enhancing, anti-depressant, anti-osteoporotic, antiviral, and anticancer chemotherapeutic activities. Tetrandrine is a Ca2+ channel blocker; it inhibits mast cell degranulation and suppresses LPS-stimulated expression of COX and inflammatory cytokines, preventing hyperalgesia in animal models. Tetrandrine also inhibits neurological deficits, decreases infarct size, and suppresses brain edema in animal models of cerebral ischemia/reperfusion. Similarly, this compound inhibits amyloid-β (Aβ)-induced memory and learning impairments in animal models of Alzheimer’s disease. In cellular and animal models of osteoporosis, tetrandrine inhibits osteoclast differentiation and prevents decrease in bone mass. This compound decreases immobility time in the forced swim test and tail suspension test and increases levels of BDNF, 5-HT, and NE in the hippocampus of animal models. In gallbladder carcinoma cells, tetrandrine induces S phase cell cycle arrest, alters the Bcl-2/Bax ratio, induces apoptosis, and inhibits proliferation. Additionally, this compound induces regression in animal models of chromic myelogenous leukemia (CML), decreasing levels of Bcr-Abl and β-catenin. Tetrandrine also prevents Ebola virus infection in animal models.

Product Info

Cas No.

518-34-3

Purity

≥98%

Formula

C38H42N2O6

Formula Wt.

622.75

Chemical Name

(1β)-6,6',7,12-Tetramethoxy-2,2'-dimethylberbaman

IUPAC Name

(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaene

Melting Point

217-218°C

Solubility

Soluble in ether. Practically insoluble in water.

Appearance

White crystal powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

T1777 MSDS PDF

Info Sheet

T1777 Info Sheet PDF

Brochures

WNT Booklet

References

Sakurai Y, Kolokoltsov AA, Chen CC, et al. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015 Feb 27;347:995-998.

Zhu R, Liu T, Tan Z, et al. Tetrandrine induces apoptosis in gallbladder carcinoma in vitro. Int J Clin Pharmacol Ther. 2014 Jul 30. [Epub ahead of print]. PMID: 25074868.

Zhao H, Luo F, Li H, et al. Antinociceptive effect of tetrandrine on LPS-induced hyperalgesia via the inhibition of IKKβ phosphorylation and the COX-2/PGE₂ pathway in mice. PLoS One. 2014 Apr 10;9(4):e94586. PMID: 24722146.

Ruan L, Huang HS, Jin WX, et al. Tetrandrine attenuated cerebral ischemia/reperfusion injury and induced differential proteomic changes in a MCAO mice model using 2-D DIGE. Neurochem Res. 2013 Sep;38(9):1871-9. PMID: 23780673.

Gao S, Cui YL, Yu CQ, et al. Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor. Behav Brain Res. 2013 Feb 1;238:79-85. PMID: 23085478.

Xu XH, Gan YC, Xu GB, et al. Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J Zhejiang Univ Sci B. 2012 Nov;13(11):867-74. PMID: 23125079.

Takahashi T, Tonami Y, Tachibana M, et al. Tetrandrine prevents bone loss in sciatic-neurectomized mice and inhibits receptor activator of nuclear factor κB ligand-induced osteoclast differentiation. Biol Pharm Bull. 2012;35(10):1765-74. PMID: 23037166.

He FQ, Qiu BY, Zhang XH, et al. Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β(1-42). Brain Res. 2011 Apr 12;1384:89-96. PMID: 21300035.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A4002

    AK-7

    SIRT2 inhibitor.

    ≥98%
  • D183736

    19-O-Desmethoxy rapamycin

    Fermentation impurity

    ≥94%
  • A4534

    Aliskiren Hemifumarate

    Renin inhibitor.

    ≥98%
  • A5272

    Angiotensin, dog/rat

    Peptide, derivative of AT I, cleavage product o...

    ≥95%
  • D3320

    Difenoconazole

    Triazole; 14-α demethylase inhibitor, potentia...

    ≥98%
  • B1898

    Bezafibrate

    Fibrate; PPARα agonist.

    ≥98%
  • T5769

    Toremifene Base

    SERM, androgen modulator.

    ≥98%
  • C017521

    Canagliflozin

    SGLT2 inhibitor

    ≥98%
  • P3441

    PIK-294

    p110δ PI3K inhibitor.

    ≥98%
  • V3212

    Vidarabine

    Nucleoside (adenosine) analog; viral DNA polyme...

    ≥98%
  • A7200

    AS-252424

    p110γ PI3K inhibitor, potential TRPC1/5/6 nega...

    ≥98%
  • T503720

    TMS

    Selective inhibitor of cytochrome P450 1B1 (CYP...

    ≥99%
  • G062680

    GBR-12909 Dihydrochloride

    Dopamine reuptake inhibitor (DRI).

    ≥98%
  • T0118

    7-epi-Cephalomannine

    Cephalomannine derivative found in Taxus; poten...

    ≥95%
  • M0114

    Madecassic Acid

    Downregulates LPS-stimulated expression of pro-...

    ≥95%
  • O9396

    Oxytetracycline

    Tetracycline; protein translation inhibitor.

    ≥96%
  • W4096

    WKYMVM-NH2

    Synthetic peptide; FPRL1 agonist.

    ≥95%
  • P0008

    Pituitary Adenylate Cyclase-activating Peptide (6-38), human/sheep/rat

    Endogenous peptide, involved in paracrine and a...

    ≥95%
  • A5034

    4-Aminosalicylic Sodium Dihydrate

    Dihydrofolate reductase inhibitor.

    ≥98%
  • C4274

    CKS-17

    Synthetic peptide, retroviral envelope protein ...

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only